THE ARCH

Where Web3 founders, talent, and partners meet.

Daily Digest · Free
PLATFORM
  • Partners Directory
  • All Categories
  • Marketplace
  • Find a Partner
  • Docs
  • Escrow
INTELLIGENCE
  • Web3 News
  • Daily Digests
  • Intel Reports
  • Web3 Events
  • RSS Feed
  • Substack ↗
GET INVOLVED
  • Get Listed
  • Get Your Verified Badge
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Book a Call
COMPANY
  • About
  • How It Works
  • Manifesto
  • Media Kit
  • Privacy
  • Terms
© 2026 THE ARCH · All rights reserved.
PRIVACYTERMSCOOKIES
THE ARCH
THE ARCH

Where Web3 founders, talent, and partners meet.

Daily Digest · Free
PLATFORM
  • Partners Directory
  • All Categories
  • Marketplace
  • Find a Partner
  • Docs
  • Escrow
INTELLIGENCE
  • Web3 News
  • Daily Digests
  • Intel Reports
  • Web3 Events
  • RSS Feed
  • Substack ↗
GET INVOLVED
  • Get Listed
  • Get Your Verified Badge
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Book a Call
COMPANY
  • About
  • How It Works
  • Manifesto
  • Media Kit
  • Privacy
  • Terms
© 2026 THE ARCH · All rights reserved.
PRIVACYTERMSCOOKIES
THE ARCH
THE ARCH
Offers
POST A BRIEFJOIN AS PARTNER
News
Novo Nordisk's Wegovy Pill Launches, Expanding Acc...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk's Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Arch TakeNeutral
AltcoinsRegulation

Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Crypto industry to contribute $55B to US economy in 2026: NCA study

Cointelegraph•1d ago

As BitMEX exits, analysts warn crypto consolidation is accelerating

Cointelegraph•1d ago

Bitcoin May Have Already Bottomed—If the Fed Helps, Says Grayscale

Decrypt •1d ago

Robinhood CEO Vlad Tenev's X account hacked to promote token amid memecoin frenzy

CoinDesk•1d ago
← Back to News Feed
THE ARCH
Offers
POST A BRIEFJOIN AS PARTNER
News
Novo Nordisk's Wegovy Pill Launches, Expanding Acc...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk's Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Arch TakeNeutral
AltcoinsRegulation

Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Crypto industry to contribute $55B to US economy in 2026: NCA study

Cointelegraph•1d ago

As BitMEX exits, analysts warn crypto consolidation is accelerating

Cointelegraph•1d ago

Bitcoin May Have Already Bottomed—If the Fed Helps, Says Grayscale

Decrypt •1d ago

Robinhood CEO Vlad Tenev's X account hacked to promote token amid memecoin frenzy

CoinDesk•1d ago
← Back to News Feed